Skip to main content
. Author manuscript; available in PMC: 2023 Sep 28.
Published in final edited form as: J Am Coll Cardiol. 2022 Jan 18;79(2):132–144. doi: 10.1016/j.jacc.2021.10.038

Table 2:

Hospital characteristics across quartiles of risk-adjusted 30-day home following the TAVR procedure

Variable Low Performing → High Performing P Value
Quartile 1 (N=163) Quartile 2 (N=163) Quartile 3 (N=163) Quartile 4 (N=163)
Number of beds Median (IQR) 423 (322–632) 414 (286–615) 440 (292–630) 383 (266–520) 0.04
Teaching affiliation (%)
Major
Minor
Non

27.6
57.7
14.7

30.3
58.0
11.7

30.9
56.2
13.0

24.7
58.0
17.3

0.8
Bundled payment (%) 43.2 50.0 43.0 50.7 0.4
Cardiac rehabilitation (%) 90.7 95.3 96.1 87.2 0.01
Ownership (%)
Government
Investor
Not for profit

7.4
19.6
73.0

8.6
13.0
78.4

9.9
14.2
75.9

5.6
9.3
85.2

0.1
Urban location
Rural location
98.2
1.8
97.5
2.5
97.5
2.5
97.5
2.5
0.9
Region (%)
Midwest
Northeast
Southeast
Southwest
West

33.3
22.2
24.1
12.4
8.0

24.7
19.1
29.6
10.5
16.1

20.1
20.1
32.7
8.2
18.9

22.2
10.8
23.4
10.1
33.5

<0.001
Length of hospital stay day after TAVR procedure Median (IQR), days 2.30 (2.0–2.7) 2.09 (1.8–2.5) 1.90 (1.7–2.3) 1.64 (1.4–2.0) <0.001
30-day home time Median (IQR), days 25.3 (24.5–25.9) 26.9 (26.7–27.2) 27.9 (27.7–28.2) 29.4 (28.9–29.9) <0.001
30-RSRR Median (IQR) (%) 16.0 (12.1–20.7) 14.0 (10.8–18.3) 12.6 (9.3–15.3) 9.2 (6.7–11.7) <0.001
30-RSMR Median (IQR) (%) 2.7 (1.5–4.0) 2.2 (1.3–3.5) 1.6 (0.9–1.5) 0.9 (0.0–1.6) <0.001
Annual TAVR Volume median (IQR) 54 (34–87) 66 (36–104) 59 (38–108) 43 (28–71) 0.05
Rate of admissions per 100 person-months at 1 year * Median (IQR) 11.9 (9.5–14.9) 11.4 (9.6–14.5) 10.1 (8.0–12.6) 8.9 (6.8–10.5) <0.001
*

Restricted to TAVR patients before 01/01/2019 to allow one year of follow up data (N=113,978 in 599 TAVR centers)

TAVR: Transcatheter aortic valve replacement; IQR: Interquartile range; RSMR: Risk-adjusted mortality rate; RSRR: Risk adjusted readmission rate